Public consultation (ARM 65): Request to reclassify Algopain-Eze 140mg Medicated Plaster from Prescription Only Medicine (POM) to pharmacy (P) - Reminder that the deadline for comments is 25 March 2010
Document details:
| Type: |
Publication |
| Series No: |
None |
| Audience: |
Healthcare professionals |
| Published: |
11 February 2010 |
| Format: |
Electronical and paper |
| Size: |
A4 |
| Pages: |
15 |
| Price: |
Free |
| ISBN/ISSN: |
None |
| Author: |
MHRA |
| Copyright: |
Crown |
| |
|
|
|
Consultation ARM 65 sought your views on the Prescription Only Medicine (POM) to Pharmacy (P) reclassification of Algopain-eze Medicated Plaster which is indicated for the local symptomatic treatment of pain in acute strains, sprains or bruises of the extremities following blunt trauma, eg sport injuries. A total of 11 responses to the consultation were received, of which six were in favour, one raised issues and three had no comment. One of the responses was confidential. Copies of the responses (excluding those marked as 'in confidence') are available below. The following table broadly indicates how pharmaceutical bodies, medical bodies, industry and others responded to the consultation.
| Professional pharmaceutical societies, individual pharmacists and other pharmaceutical bodies |
|
Yes to proposal
|
|
Issues raised
|
| Medical Profession and Royal Colleges |
|
No comment
|
|
Issues raised
|
| Industry and trade Associations |
|
Yes to proposal
|
|
Page last modified:
17 January 2011
Public consultation (ARM 65): Request to reclassify Algopain-Eze 140mg Medicated Plaster from Prescription Only Medicine (POM) to pharmacy (P)